Cel Sci CVM
NYSE CVM
$1.32 -0.08 (-5.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Cel Sci (CVM) Asset Writedowns and Impairment (2021 - 2026)

Updated

Cel Sci (CVM) recorded Asset Writedowns and Impairment of $30,793 in FY2022 (year ended Sep 30, 2022).

Analysis

Cel Sci (CVM) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cel Sci 58.11 Mn 32.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 22,257.00
Dec 31, 2025 12,851.00
Sep 30, 2025 4,963.00
Jun 30, 2025 3,771.00
Dec 31, 2024 9,541.00
Dec 31, 2021 30,793.00
API Access

Cel Sci Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CVM&period=max&api_key=YOUR_API_KEY